tiprankstipranks
Trending News
More News >
Anixa Biosciences (ANIX)
NASDAQ:ANIX
US Market

Anixa Biosciences (ANIX) Financial Statements

Compare
505 Followers

Anixa Biosciences Financial Overview

Anixa Biosciences's market cap is currently $110.48M. The company's EPS TTM is $-0.389; its P/E ratio is -9.56; Anixa Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 210.00K$ 0.00$ 512.00K
Gross Profit$ -36.00K$ -37.00K$ 49.00K$ 0.00$ 127.00K
Operating Income$ -11.70M$ -13.83M$ -11.01M$ -13.88M$ -13.14M
EBITDA$ -11.70M$ -12.66M$ -10.96M$ -13.73M$ -13.08M
Net Income$ -10.93M$ -12.55M$ -9.81M$ -13.60M$ -12.95M
Balance Sheet
Cash & Short-Term Investments$ 15.17M$ 19.92M$ 23.84M$ 29.69M$ 35.73M
Total Assets$ 16.08M$ 21.59M$ 25.52M$ 30.41M$ 36.26M
Total Debt$ 204.00K$ 232.00K$ 175.00K$ 221.00K$ 259.00K
Net Debt$ -1.04M$ -1.04M$ -740.00K$ -12.14M$ -28.83M
Total Liabilities$ 2.13M$ 2.70M$ 2.15M$ 2.21M$ 1.49M
Stockholders' Equity$ 15.16M$ 20.00M$ 24.34M$ 29.05M$ 35.44M
Cash Flow
Free Cash Flow$ -7.17M$ -7.33M$ -6.21M$ -6.49M$ -4.94M
Operating Cash Flow$ -7.17M$ -7.33M$ -6.21M$ -6.49M$ -4.94M
Investing Cash Flow$ 4.87M$ 4.28M$ -5.60M$ -10.73M$ -3.92M
Financing Cash Flow$ 2.28M$ 3.42M$ 366.00K$ 452.00K$ 31.57M
Currency in USD

Anixa Biosciences Earnings and Revenue History

Anixa Biosciences Debt to Assets

Anixa Biosciences Cash Flow

Anixa Biosciences Forecast EPS vs Actual EPS